V. Mikol
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 10%
- HIV/AIDS drug development and treatment
Papers in
-
- Signaling Pathways in Disease 5
- Protein Structure and Dynamics 2
-
- Toxin Mechanisms and Immunotoxins 3
- Immunodeficiency and Autoimmune Disorders 2
- Co-authors
- Richard Giegé (3 shared papers)J.P. Guilloteau (2 shared papers)Ernest Hirsch (2 shared papers)S. Maignan (1 shared paper)Qing Zhou-Liu (1 shared paper)Malcolm D. Walkinshaw (4 shared papers)Jörg Kallen (3 shared papers)Alexey Rak (1 shared paper)
- Journals
- Journal of Molecular Biology (5 papers)Journal of Applied Crystallography (2 papers)Protein Engineering Design and Selection (1 paper)British Journal of Dermatology (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)
- Partner nations
- FranceUnited StatesCanada
In The Last Decade
V. Mikol
19 papers receiving 724 citations
Peers
Comparison fields: 5 of 83
- Virology 162
- Infectious Diseases 186
- Molecular Biology 497
- Pharmacology 91
- Toxicology 13
Countries citing papers authored by V. Mikol
This map shows the geographic impact of V. Mikol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Mikol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Mikol more than expected).
Fields of papers citing papers by V. Mikol
This network shows the impact of papers produced by V. Mikol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Mikol. The network helps show where V. Mikol may publish in the future.
Co-authors
The 25 scholars most cited alongside V. Mikol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 236 | |
| 2 | 2009 | 129 | |
| 3 | 1990 | 110 | |
| 4 | 1994 | 82 | |
| 5 | 1988 | 44 | |
| 6 | 1989 | 34 | |
| 7 | 1989 | 30 | |
| 8 | 1994 | 12 | |
| 9 | 1998 | 12 | |
| 10 | 2025 | 10 | |
| 11 | Anti-lipopolysaccharide core antibodies. | 1994 | 10 |
| 12 | 1996 | 8 | |
| 13 | 1996 | 7 | |
| 14 | 2004 | 7 | |
| 15 | 1991 | 6 | |
| 16 | 2025 | 2 | |
| 17 | 2025 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 1994 | 1 |
About V. Mikol
V. Mikol is a scholar working on Molecular Biology, Immunology, Materials Chemistry, Organic Chemistry and Genetics, having authored 19 papers that have together received 744 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), Enzyme Structure and Function (4 papers), Toxin Mechanisms and Immunotoxins (3 papers), Protein Structure and Dynamics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Crystallization and Solubility Studies (2 papers). The work is most often cited by research in Virology (162 citations), Infectious Diseases (186 citations), Molecular Biology (497 citations), Pharmacology (91 citations) and Toxicology (13 citations). V. Mikol has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Richard Giegé, J.P. Guilloteau, Ernest Hirsch, S. Maignan, Qing Zhou-Liu, Malcolm D. Walkinshaw, Jörg Kallen, Alexey Rak, Franck Augé and François Vallée. Their work appears in journals such as Journal of Molecular Biology, Journal of Applied Crystallography, Protein Engineering Design and Selection, British Journal of Dermatology and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.